CBD may help avert lung destruction in COVID-19
Global research community asks for the right research in the right places for COVID-19
Johnson & Johnson Tops Q2 Estimates; Raises 2020 Guidance
ICMRA seeks international alignment on COVID-19 product assessment
Daily Market News: Twitter share price takes a hit on security concerns
BioNTech (BNTX): Fast Track Designation Does Not Justify Current Valuation, Says J.P. Morgan
A new anti-platelet drug shows potential for treating blood vessel clots in heart attacks, strokes and, possibly, COVID-19
Penn researchers find three distinct immune responses for sicker COVID-19 patients
Vaccine alliance says 75 countries keen to join “COVAX” access facility
Russian scientists hail results of COVID-19 vaccine trial
Merck CEO Expresses Concern About Rapid Covid-19 Vaccine Development
A nanomaterial path forward for COVID-19 vaccine development
VXRT Stock Price Jumps on COVID-19 Operation Warp Speed Announcement
Moderna Phase 1 results show coronavirus vaccine safe, induces immune response
Experimental COVID-19 vaccine safe, generates immune response
Kancera’s Unique Approach to COVID-19
IMV Pops 134% In Pre-Market On “Rapid Progress” Of Covid-19 Vaccine Development
Biogen, Eisai Start New Phase 3 Trial For Pre-clinical Alzheimer's Disease
Keck Medicine of USC enrolling patients as part of international clinical trial to study antiviral drug as treatment for COVID-19
Voices from the front line in rare disease
Artemisinin: fighting coronavirus with this antimalarial drug is risky
U.S. Covid-19 vaccine program to start manufacturing by late summer
COVID-19: Considering meditation and yoga as adjunctive treatment
Could pressure for COVID-19 drugs lead the FDA to lower its standards?
Gilead Reveals Additional Data On Covid-19 Treatment Remdesivir
HHS allocates Gilead’s Covid-19 drug remdesivir to four hardest hit states
Remdesivir Shows Broader Effectiveness Against Covid-19
Virtual healthcare during pandemic has won patients over; survey
New study supports remdesivir as COVID-19 treatment
Genexine and NeoImmuneTech (NIT) – GX-I7 [also called NT-17 or Hyleukin-7™ (rhIL-7-hyFc)]